Pharmacodynamic interactions among atovaquone, proguanil and cycloguanil against Plasmodium falciparum in vitro

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 97, Issue 3, 2003, Pages 331-337

  Thapar, Mita M ^a   Gupta, Seema ^a   Spindler, Carl ^a   Wernsdorfer, Walther H ^b   Björkman, Anders ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Atovaquone; Chemotherapy; Cycloguanil; In vitro; Malaria; Malarone ; Pharmacodynamics; Plasmodium falciparum; Proguanil

Indexed keywords

AMINOBENZOIC ACID DERIVATIVE; ATOVAQUONE; ATOVAQUONE PLUS PROGUANIL; CYCLOGUANIL; DIHYDROFOLATE REDUCTASE; FOLIC ACID; PROGUANIL;

ANALYTIC METHOD; ARTICLE; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION COEFFICIENT; CULTURE MEDIUM; DRUG EFFICACY; GROWTH INHIBITION; IN VITRO STUDY; LABORATORY TEST; NONHUMAN; PLASMODIUM FALCIPARUM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STEADY STATE;

ANIMALS; ANTIMALARIALS; ATOVAQUONE; CHLOROGUANIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG SYNERGISM; NAPHTHOQUINONES; PLASMODIUM FALCIPARUM; TRIAZINES;

PLASMODIUM FALCIPARUM;

EID: 4444304344     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(03)90162-3     Document Type: Article

References (27)

1. Anabwani G. Canfield C.J. Hutchinson D.B. Combination atovaquone and proguanil hydrochloride vs. halofantrine for treatment of acute Plasmodium falciparum malaria in children Pediatric Infectious Disease Journal 18 1999 456-461
2. Berenbaum M.C. A method for testing for synergy with any number of agents Journal of Infectious Diseases 137 1978 122-130
3. Canfield C.J. Pudney M. Gutteridge W.E. Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro Experimental Parasitology 80 1995 373-381
4. Chiodini P.L. Conlon C.P. Hutchinson D.B. Farquhar J.A. Hall A.P. Peto T.E. Birley H. Warrell D.A. Evaluation of atovaquone in the treatment of patients with uncomplicated Plasmodium falciparum malaria Journal of Antimicrobial Chemotherapy 36 1995 1073-1078
5. Daniel W.W. A Foundation for Analysis in the Health Sciences 1991 Wiley & Sons New Yorke
6. Edstein M.D. Yeo A.E.T. Kyle D.E. Looareesuwan S. Wilairatana P. Rieckmann K.H. Proguanil polymorphism does not affect the antimalarial activity of proguanil combined with atovaquone in vitro Transactions of the Royal Society of Tropical Medicine and Hygiene 90 1996 418-421
7. Eriksson B. Lebbad M. Björkman A. In vitro activity of proguanil, chlorproguanil and their main metabolites against Plasmodium falciparum Transactions of the Royal Society of Tropical Medicine and Hygiene 83 1989-488
8. Fidock D.A. Nomura T. Wellems T.E. Cycloguanil and its parent compound proguanil demonstrate distinct activities against Plasmodium falciparum malaria parasites transformed with human dihydrofolate reductase Molecular Pharmacology 54 1998 1140-1147
9. Farnert A. Lindberg J. Gil P. Swedberg G. Berqvist Y. Thapar M.M. Lindegardh N. Berezczy S. Bjorkman A. Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: Case reports British Medical Journal 326 2003 628-629
10. Fivelman Q.L. Butcher G.A. Adagu I.S. Warhurst D.C. Pasvol G. Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria Malaria Journal 1 2002 1
11. Fry M. Pudney M. Site of action of the antimalarial hydroxynaphthoquinone, 2-[Tans-4- (4′-chlorophenyl) cyclohexyl]-3-hydroxy-1,4-naphthoquinone (566C80) Biochemical Pharmacology 43 1992 1545-1553
12. Gupta S. Thapar M.M. Wernsdorfer W.H. Bjorkman A. In vitro interactions of artemisinin with atovaquone, quinine, and mefloquine against Plasmodium falciparum Antimicrobial Agents and Chemotherapy 46 2002 1510-1515
13. Hassan Alin M. Björkman A. Wernsdorfer W.H. Synergism of benflumetol and artemether in Plasmodium falciparum American Journal of Tropical Medicine and Hygiene 61 1999 439-445
14. Hudson A.T. Dickins M. Ginger C.D. Gutteridge W.E. Holdich T. Hutchinson D.B. Pudney M. Randall A.W. Latter V.S. 566C80: A potent broad spectrum anti-effective agent with activity against malaria and opportunistic infections in AIDS patients Drugs under Experimental and Clinical Research 17 1991 427-435
15. Kaneko A. Bergqvist Y. Takechi M. Kalkoa M. Kaneko O. Kobayakawa T. Ishizaki T. Bjorkman A. Intrinsic efficacy of proguanil against falciparum and vivax malaria independent of the metabolite cycloguanil Journal of Infectious Diseases 179 1999 974-979
16. Korsinczky M. Chen N. Kotecka B. Saul A. Rieckmann K. Cheng Q. Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site Antimicrobial Agents and Chemotherapy 44 2000 2100-2108
17. Litchfield J.T. A simplified method of evaluating dose-effect experiments Journal of Pharmacology and Experimental Therapeutics 96 1949 99-113
18. Looareesuwan S. Viravan C. Webster H.K. Kyle D.E. Hutchinson D.B. Canfield C.J. Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand American Journal of Tropical Medicine and Hygiene 54 1996 62-66
19. Looareesuwan S. Wilairatana P. Chalermarut K. Rattanapong Y. Canfield C.J. Hutchinson D.B.A. Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand American Journal of Tropical Medicine and Hygiene 60 1999 526-532
20. Olliaro P. Mode of action and mechanisms of resistance for antimalarial drugs Pharmacology and Therapeutics 89 2001 207-219
21. Radloff P.D. Philipps J. Hutchinson D. Kremsner P.G. Atovaquone plus proguanil is an effective treatment for Plasmodium ovale and P. malariae malaria Transactions of the Royal Society of Tropical Medicine and Hygiene 90 1996 682
22. Sirawaraporn W. Sathitkul T. Sirawarapom R. Yuthavong Y. Santi D.V. Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase Proceedings of the National Academy of Sciences of the USA 94 1997 1124-1129
23. Srivastava I.K. Vaidya A.B. A mechanism for the synergistic antimalarial action of atovaquone and proguanil Antimicrobial Agents and Chemotherapy 43 1999 1334-1339
24. Sucharit F. Tiewcharoen S. Chintana T. Suphadtanaphongs V. Sucharit S. In vivo studies on the sensitivities of Plasmodium falciparum in Thailand to pyrimethamine and proguanil Annals of Tropical Medicine and Parasitology 79 1985 375-377
25. Thapar M.M. Ashton M. Lindegardh N. Bergqvist Y. Nivelius S. Johansson I. Bjorkman A.Timedependent pharmacokinetics and drug metabolism of atovaquone plus proguanil (Malarone) when taken as chemoprophylaxis European Journal of Clinical Pharmacology 58 2002 19-27
26. Trager W. Jensen J.B. Human malaria parasites in continuous culture Science 193 1976 673-675
27. Watkins W.M. Sixsmith D.G. Chulay J.D. The activity of proguanil and its metabolites, cycloguanil and p-chlorophenylbiguanide, against Plasmodium falciparum in vitro Annals of Tropical Medicine and Parasitology 78 1984 273-278